Microsoft Announces Call for Entries for Expanded Pharmaceutical and Life Sciences Innovation Awards
Awards broadened, internationalized to showcase solutions in sales and marketing, manufacturing and supply chain, and clinical development.
REDMOND, Wash. – Feb. 27, 2006 – Microsoft Corp. today announced a call for entries for its Microsoft® Pharmaceutical and Life Sciences Innovation Awards, recognizing breakthroughs in the use of technology in three award categories.
Awarded annually, this year's competition is expanded in recognition of the positive impact that new and innovative technologies are delivering in the areas of sales and marketing, manufacturing and supply chain, and clinical development.
Eligible participants are pharmaceutical and life sciences corporations, including those in biotechnology, diagnostics, medical equipment and devices, pharmaceuticals, animal health, nutritional products, and consumer health products. This year, for the first time, the awards are open to corporations worldwide.
An award will be presented in each category to eligible pharmaceutical or life sciences corporations that best demonstrate market leadership in improving business operations through deployment of Microsoft technologies representing breakthroughs in business processes and practices.
Sales and Marketing
This award recognizes technological innovation that enhances a pharmaceutical or life sciences corporation's ability to inform and educate physicians and healthcare professionals, consumers, and even insurance and benefits plan providers about the benefits, value and safety of the pharmaceutical and healthcare offerings produced. Last year's winner in this category, Pfizer Inc., was honored for its use of industry-leading technologies to provide physicians and healthcare professionals with up-to-date and visually appealing information, which enables them to quickly make informed patient-treatment decisions.
Manufacturing and Supply Chain
This award recognizes the use of innovative technology to improve a pharmaceutical or life sciences corporation's ability to expedite delivery of products to consumers by reducing complexity and costs, improving productivity, and enhancing product life-cycle management, compliance, safety, quality and speed to use through advancements in manufacturing and supply chain.
Clinical Development
To address the rising costs and pipeline pressures in the development of new drugs and other life sciences products, it is increasingly imperative for companies to implement innovative technologies that accelerate discovery and bring critical new products to market quickly and more safely. The winner in this category will be the pharmaceutical or life sciences company demonstrating innovative use of Microsoft technologies in drug development, biotechnology, medical and diagnostic devices, or animal health and consumer health products resulting in faster market delivery by enhancing the speed and quality of clinical trials and product development, reducing complexity and costs, and delivering safer products to consumers globally.
Awards Schedule
Implementations for award consideration must include the use of Microsoft technologies such as BizTalk® Server, Windows® XP Tablet PC Edition, SQL Server™ 2005, Office 2003 or other major Microsoft technologies. An online entry kit and full details are available on the Microsoft Life Sciences Web site at www.microsoft.com/lifesciences. Entries must be submitted online by 5 p.m. PST Monday, April 10, 2006. Winners will be announced before the end of June 2006. More information about the awards is also available by contacting Monika Skibeness at Monika_TCS@msn.com or +1 (425) 316-3079.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
